Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Lemoine

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|July 13, 2002
10th International Conference on Gene Therapy of Cancer. 13-15 December, 2001, Sidney Kimmel Cancer Center, San Diego, CA, USANick Lemoine
Expert Review of Anticancer Therapy|July 3, 2004
Assessing cancer riskJohn Burn, Nick Lemoine, Liam O'Toole
Journal of the National Cancer Institute|January 8, 2004
Re: Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidityGabriele Capurso, Gianfranco Delle Fave, Nick Lemoine
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potencyTa-Chiang Liu, Gunnel Hallden, Yaohe Wang, et al.
International Journal of Cancer|March 29, 2002
Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID micePhilip Savage, Pam Cowburn, Aled Clayton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenovirusesYaohe Wang, Stephen Thorne, Joseph Hannock, et al.
Nature Biotechnology|October 14, 2003
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor modelsYaohe Wang, Gunnel Hallden, Richard Hill, et al.
International Journal of Molecular Sciences|January 27, 2024
Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) ModelsTizong Miao, Alistair Symonds, Oliver J Hickman, et al.
The Journal of Clinical Investigation|May 5, 2009
CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cellsYaohe Wang, Rathi Gangeswaran, Xingbo Zhao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|July 13, 2002
10th International Conference on Gene Therapy of Cancer. 13-15 December, 2001, Sidney Kimmel Cancer Center, San Diego, CA, USANick Lemoine
Expert Review of Anticancer Therapy|July 3, 2004
Assessing cancer riskJohn Burn, Nick Lemoine, Liam O'Toole
Journal of the National Cancer Institute|January 8, 2004
Re: Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidityGabriele Capurso, Gianfranco Delle Fave, Nick Lemoine
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potencyTa-Chiang Liu, Gunnel Hallden, Yaohe Wang, et al.
International Journal of Cancer|March 29, 2002
Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID micePhilip Savage, Pam Cowburn, Aled Clayton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenovirusesYaohe Wang, Stephen Thorne, Joseph Hannock, et al.
Nature Biotechnology|October 14, 2003
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor modelsYaohe Wang, Gunnel Hallden, Richard Hill, et al.
International Journal of Molecular Sciences|January 27, 2024
Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) ModelsTizong Miao, Alistair Symonds, Oliver J Hickman, et al.
The Journal of Clinical Investigation|May 5, 2009
CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cellsYaohe Wang, Rathi Gangeswaran, Xingbo Zhao, et al.
Pageof 1